Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
House dust mite allergens are proteins derived from two primary species of mites: *Dermatophagoides farinae* and *Dermatophagoides pteronyssinus*. These allergens are a leading cause of allergic sensitization globally, inducing allergic rhinitis, asthma exacerbations, and atopic dermatitis. The major allergenic proteins include Der f 1, Der f 2, Der f 11, and Der f 23 for *D. farinae*, and Der p 1 and Der p 2 for *D. pteronyssinus*. Exposure occurs primarily through inhalation, ingestion or direct contact with contaminated materials, triggering an IgE-mediated hypersensitivity reaction. Immunotherapy is available for diagnosis and treatment.
IgE-mediated hypersensitivity reaction triggered by inhalation or contact with mite allergens, leading to mast cell degranulation and release of inflammatory mediators.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on House dust mite allergens (Dermatophagoides farinae, Dermatophagoides pteronyssinus).